Top brokerage firm Motilal Oswal suggests investors buying the stocks of Sun Pharma. The company's API sales increased by 16.3% YoY to Rs. 6b in 1QFY23, while gross margin increased marginally by 15bp YoY to 73.9% in 1QFY23.
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/7Vd26oF
via IFTTT
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/7Vd26oF
via IFTTT